AiXin Life director and officer Wang resigns

AiXin Life International, Inc. reported that its Board of Directors accepted the resignation of director Yao-te Wang, effective January 26, 2026.

Rhea-AI Filing Summary

AiXin Life International, Inc. reported that its Board of Directors accepted the resignation of director Yao-te Wang, effective January 26, 2026. At the same time, Mr. Wang was removed from all officer roles he held at the company and its subsidiaries. The filing does not describe any replacement or other changes, focusing solely on his departure from the board and executive positions.

Insights

Corporate governance analyst

AiXin reports a board and officer departure without added context.

AiXin Life International, Inc. disclosed that director Yao‑te Wang resigned effective January 26, 2026, and was simultaneously removed from all officer positions at the company and its subsidiaries. The event is framed strictly as a leadership change, with no additional narrative.

The filing does not specify reasons for the resignation or indicate any related strategic shift, compensation changes, or board restructuring. It also does not identify successors for Mr. Wang’s officer roles, so the scope is limited to acknowledging his departure.

From an investor perspective, this is a governance update rather than a quantified financial event. Any further implications would depend on future disclosures that might detail how the company reallocates responsibilities formerly held by Mr. Wang.

8-K Event Classification

2 items: 5.02, 9.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What leadership change did AiXin Life International (AIXN) disclose?

AiXin Life International disclosed that director Yao-te Wang resigned effective January 26, 2026. At the same time, he was removed from all officer positions at the company and its subsidiaries, making this a combined board and management-level departure rather than a narrow board change.

When did AiXin Life International (AIXN) accept Yao-te Wang’s resignation?

The Board of AiXin Life International accepted Yao-te Wang’s resignation on January 27, 2026. His resignation as a director, and removal from all officer positions, was effective January 26, 2026, creating a one-day gap between effectiveness and formal board acceptance.

Did AiXin Life International (AIXN) remove Yao-te Wang from officer roles as well?

Yes. In addition to accepting his resignation as a director, AiXin Life International removed Yao-te Wang from all officer positions he held in the company or any subsidiaries. The disclosure emphasizes that the change covers both board membership and executive responsibilities.

Does AiXin Life International (AIXN) name a replacement for Yao-te Wang?

The disclosure does not name any replacement for Yao-te Wang as a director or officer. It focuses solely on acknowledging his resignation and removal from all officer roles, without describing succession plans or interim appointments in leadership roles.

What stock listing information is provided for AiXin Life International (AIXN)?

AiXin Life International’s common stock is listed with the trading symbol AIXN on the OTCQB market. This information is included alongside the leadership change disclosure, confirming the class of securities and the marketplace where the shares trade.

Where is AiXin Life International (AIXN) headquartered according to the filing?

The filing states that AiXin Life International’s principal executive offices are in Chengdu City, Sichuan Province, China. The address is Hongxing International Business Building 2, 14th Floor, No. 69 Qingyun South Avenue, providing geographic context for the company’s operations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/28/2026 - 08:00 AM Learn about SEC filing dates

false 0000835662 0000835662 2026-01-26 2026-01-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): January 26, 2026

AIXIN LIFE INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

Colorado		0-17284		84-1085935
State of		Commission		IRS Employer
Incorporation				Identification No.

Hongxing International Business Building 2, 14th FL, No. 69 Qingyun South Ave., Jinjiang District

Chengdu City, Sichuan Province, China

(Address of principal executive offices)

 610021

86-313-6732526

(Issuer’s telephone number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock		AIXN		OTCQB

Item 5.02 Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On January 27, 2026, the Company’s Board of Directors accepted the resignation of Mr. Yao-te Wang from his position as a director of the Company effective January 26, 2026. Concurrent with the acceptance of Mr. Wang’s resignation from the Board of Directors of the Company, he was removed from all officer positions held in the Company or any of its subsidiaries.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.		Description
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AiXin Life International, Inc.
Date: January 28, 2026	By:	/s/ Quanzhong Lin
		Quanzhong Lin
		Chief Executive Officer